Suppr超能文献

未经治疗的头颈部鳞状细胞癌患者的预后及预后因素

Outcomes and Prognostic Factors in Patients With Untreated Head and Neck Squamous Cell Carcinoma.

作者信息

Kessoku Hisashi, Mizunari Yosuke

机构信息

Department of Otorhinolaryngology, Jikei University Kashiwa Hospital, Kashiwa, JPN.

出版信息

Cureus. 2025 Jan 8;17(1):e77141. doi: 10.7759/cureus.77141. eCollection 2025 Jan.

Abstract

OBJECTIVES

Although several studies have reported the treatment prognosis in squamous cell carcinoma of the head and neck, few studies exist on the prognosis and mortality-related risk factors in untreated cases. This study aimed to determine the outcomes of patients with head and neck squamous cell carcinoma who underwent no treatment and investigate the associated factors.

METHODS

This retrospective, single-institution study initially included 718 patients with head and neck cancer who visited our hospital between January 2015 and December 2021; 43 untreated patients were included in the final analysis. This study was conducted in Japan, where universal health insurance ensures access to treatment for all citizens.

RESULTS

The median patient age was 79 years, with a predominance of male patients. The primary reasons for patients being untreated were patient refusal, dementia, and advanced age. The median survival time for untreated patients was 20.5 weeks, with 90% succumbing within one year of their first visit. Univariate analyses showed that an advanced clinical stage (stage IV) was a major determinant of survival. In patients with stage IV disease, living alone or without family support was the sole significant predictor of a poor prognosis.

CONCLUSIONS

Our results inform healthcare providers about the consequences of not providing treatment and patients regarding treatment choices.

摘要

目的

尽管已有多项研究报道了头颈部鳞状细胞癌的治疗预后,但关于未经治疗病例的预后及与死亡率相关的危险因素的研究却很少。本研究旨在确定未接受治疗的头颈部鳞状细胞癌患者的结局,并调查相关因素。

方法

这项回顾性单机构研究最初纳入了2015年1月至2021年12月期间到我院就诊的718名头颈部癌症患者;最终分析纳入了43例未接受治疗的患者。本研究在日本进行,该国的全民健康保险确保所有公民都能获得治疗。

结果

患者的中位年龄为79岁,男性患者居多。患者未接受治疗的主要原因是患者拒绝、痴呆和高龄。未接受治疗患者的中位生存时间为20.5周,90%的患者在首次就诊后一年内死亡。单因素分析表明,临床晚期(IV期)是生存的主要决定因素。在IV期疾病患者中,独居或没有家庭支持是预后不良的唯一显著预测因素。

结论

我们的结果为医疗服务提供者提供了关于不进行治疗的后果的信息,并为患者提供了有关治疗选择的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fc/11717383/a91e7ca223c9/cureus-0017-00000077141-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验